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Abstract
We used data from a prospective study of 300 women attending a sexually transmitted infection 
clinic in Kingston, Jamaica, to compare participant self-report of recent semen exposure to actual 
semen exposure measured by prostate-specific antigen in vaginal swabs. Underreporting of semen 
exposure was significantly more frequent at follow-up than baseline, suggesting the accuracy of 
reports of sexual behavior may vary over time.
Study participants may misreport sexual behaviors (intentionally or not). Efforts to quantify 
misreporting have ranged widely from measuring self-reported virginal status among 
pregnant women1 or sexually transmitted infections (STIs) among young adults reporting 
sexual abstinence2 to detecting biological markers such as semen among women reporting 
no recent sexual exposure3 and drug levels in hair as evidence of pre-exposure prophylaxis 
use.4 Despite the increasing recognition of the need for improved measures, HIV prevention 
studies continue to depend on participant reports of sensitive behaviors. This practice is 
problematic. For example, the association detected in observational studies between 
injectable contraception and HIV acquisition5 could be explained by differential condom use 
between study arms. Hormonal contraception users might have more unprotected sex with 
HIV-infected partners than nonusers, yet participant reports of sexual activity and condom 
use may be inadequate for controlling for this difference in risk.6
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One argument supporting continued use of self-reported measures could be that any 
misreporting is assumed to be nondifferential between arms in comparison trials or in a 
population over time, which would tend to conservatively bias results toward the null.7 To 
examine this question, we assessed the consistency of misreporting over time by comparing 
self-reports to a semen biomarker at baseline and follow-up among females participating in a 
trial on the effectiveness of counseling messages conducted during 2010–2011.8
Participants consisted of nonpregnant, HIV-negative women ≥18 years of age attending a 
public STI clinic in Kingston, Jamaica who were prescribed syndromic treatment for 
cervicitis or vaginal discharge according to standard care.8 Women were randomized to 
receive a counseling message promoting either abstinence alone or abstinence backed up by 
promotion and provision of condoms for the treatment period of ≥7 days. At enrollment and 
the 6-day follow-up visit, a study clinician collected vaginal swabs to test for prostate-
specific antigen (PSA), and study staff administered a questionnaire. Women had to give 
written consent for screening, enrollment and PSA testing to be part of this analysis. Ethical 
review committees at the Jamaican Ministry of Health and the US Centers for Disease 
Control and Prevention approved the research.
PSA detected in vaginal fluid is a marker of semen exposure occurring within the past 48 
hours.9 On-site laboratory staff used previously described methods10 to test for PSA with 
ABAcard p30 (Abacus Diagnostics, West Hills, CA), which produces results that can be 
interpreted semi-quantitatively (negative, low positive, or high positive). We dichotomized 
the results (negative versus low or high positive). We used a chi-squared test to evaluate 
differences between enrollment and follow-up visits in the proportion of women who self-
reported no recent semen exposure (i.e., either no sex without a condom or no sex in the past 
2 days) among those with PSA positivity.
Of 300 women enrolled in the trial, 7 failed to return for follow up, 7 declined to consent to 
PSA testing, and 1 had missing PSA data at enrollment. Thus, the current analysis is based 
on 286 women (95% of randomized women) who completed 571 visits (285 enrollment and 
286 follow-up visits). Altogether, 16.8% of participants (48/286) had PSA detected at ≥1 
study visit. Similar proportions of women had PSA detected at enrollment (8.4%) and follow 
up (10.1%) (Figure). Fifteen percent of women reported having sex without a condom in the 
past 2 days, with similar percentages at enrollment (15.3%) and follow up (14.7%). Among 
visits where PSA was detected, however, in nearly two-thirds (64%) of visits, the participant 
denied having unprotected sex in the preceding 2 days. Notably, the proportion of women 
with biological evidence of semen exposure who reported no unprotected sex increased 
significantly between enrollment (50%) and follow up (75.9%) (P=0.05).
Women may have perceived more pressure not to disclose unprotected sex at follow up 
because of the counseling at enrollment, which instructed them to be abstinent while on 
syndromic treatment. As previously revealed in a qualitative study conducted among a 
subset of the participants informed about their PSA positivity (following rapid testing at 
follow up), this social desirability bias may have prevented women from reporting failure to 
adhere to clinic staff’s instructions.11 In contrast, at enrollment, women were asked to report 
on their behaviors, including unprotected sex, before any counseling messages were 
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provided. Whether misreporting would have regressed to baseline levels (from participants 
becoming desensitized to counseling messages) or would have increased (from effect of 
cumulative messages) had our trial been longer is unknown. A previous study of female sex 
workers in Kenya, which compared participant reports and PSA outcomes at both 
enrollment and 12-month follow-up visits, did not find differences in discordancy between 
the two study visits.12 Collectively, these findings suggest that the changes in accuracy 
could differ by study population, research question, or trial procedures.
A recent analysis found no evidence of differential misclassification of semen exposure 
between hormonal contraception users and nonusers.13 Previous studies, though, have found 
that having discordant biological and self-reported measures of semen exposure was 
associated with a range of characteristics and behaviors: study site, race/ethnicity, age, 
education, use of amphetamine-type stimulants, self-reported injection drug use, number of 
partners, self-perceived risk of HIV infection, or infection with HIV, human papillomavirus, 
bacterial vaginosis, or chlamydia.14–17 This further evidence that misclassification does not 
occur at random suggests that attempts to adjust for self-reported condom use could actually 
introduce bias, occurring in any direction.
Identifying those women at risk of HIV/STIs from engaging in unprotected sex could be 
useful in many settings. Public health interventions to prevent these diseases could improve 
their efficiency by targeting sexually-active people who are not consistent condom users. 
Also, research on interventions to prevent HIV/STIs could benefit from collection of 
objective biologic measures of semen exposure. The interpretation of data from HIV 
prevention trials involving only self-reports from participants is more complicated than 
previously suspected given the present results indicating that participant underreports of 
semen exposure may change over time.
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Participant underreporting of exposure to semen increased over time. Misclassification of 
participant reports of sensitive behaviors cannot be assumed to occur at random.
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Reported versus actual semen exposurea among women attending a sexually transmitted 
infection clinic (n=300), Kingston, Jamaica, 2010–2011
aAs determined by vaginal fluid swabs testing positive for prostate-specific antigen, a 
marker of semen exposure.
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